Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
246.00    0.20 (0.08%)
Bid:
247.00
Ask:
248.20
Spread: 1.20 (0.486%)
Market Cap: £951.09m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Stabilisation Notice

7 Sep 2021 17:52

RNS Number : 0371L
Morgan Stanley & Co. Int'l plc
07 September 2021
 

2021/09/07

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trustpilot Group plc

Post-Stabilisation Notice

Morgan Stanley & Co. International plc (contact: James Cresswell; telephone: +44 (0)20 7677 0981) hereby gives notice that it undertook stabilisation (within the meaning of Article 3(2)(d) of Regulation (EU) 596/2014, including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018)) in relation to the offer of the following securities, as set out below.

Issuer

Trustpilot Group plc

ISIN

GB00BNK9TP58

Description

Ordinary registered shares ("ORDs" or "Ordinary Shares") of the Issuer

Stabilisation Manager(s)

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Offer Price

265 pence per Offer Share

Offer Size

178,596,461 Ordinary Shares (excluding the over-allotment option)

Stabilisation Started

2021/03/23

Stabilisation Last Occurred

2021/04/06

Price Range of Stabilisation Trades

GBP 2.5000 - GBP 2.6500

Stabilisation Trading Venue

London Stock Exchange multilateral trading facility MTF (XLOM); London Stock Exchange (XLON); Turquoise Lit Auctions (TRQA); Turquoise (TRQX); Turquoise Plato (TRQM); CBOE Europe - CXE Dark Order Book (CHID); POSIT Dark (XPOS); Morgan Stanley and Co. International PLC - Systematic Internaliser (MSSI); Morgan Stanley and Co. International Plc (MSIP)

 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

 

 

 

Date

Lowest Price

(GBP)

Highest Price

(GBP)

Trading Venue

2021/03/23

2.6500

2.6500

XLOM

2021/03/24

2.5000

2.6500

XLOM, MSIP, MSSI

2021/03/25

2.5560

2.6500

XLOM, MSIP

2021/03/26

2.6200

2.6500

XLON

2021/03/29

2.5808

2.6500

XLON, XPOS, TRQX, TRQM

2021/03/30

2.6000

2.6500

XLON, XPOS, TRQX, TRQA

2021/03/31

2.6270

2.6500

XLON, XPOS, TRQX, TRQM, CHID, MSIP

2021/04/01

2.6340

2.6500

XLON, TRQX

2021/04/06

2.6500

2.6500

XLON

 

For details of the options granted by certain of the selling shareholders to the underwriters (so called Greenshoe Option) please refer to the notice dated 16 April 2021: https://www.investegate.co.uk/trustpilot-group-plc/rns/exercise-of-over-allotment-option/202104161739337979V/ 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

END.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STALRMFTMTIMBLB
Date   Source Headline
11th Jan 20247:10 amRNSDirectorate Change
11th Jan 20247:00 amRNSTrading update for the year ended 31 December 2023
11th Jan 20247:00 amRNSShare Buyback Programme
2nd Jan 20247:00 amRNSBlock listing Interim Review
29th Dec 20231:27 pmRNSTotal Voting Rights
30th Nov 20232:28 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSBlock Listing Application
31st Oct 20232:04 pmRNSTotal Voting Rights
13th Oct 202311:17 amRNSTR-1 - Notification of major holdings
13th Oct 20239:38 amRNSBoard Committee Membership Changes
11th Oct 20237:00 amRNSResult of secondary placing in Trustpilot
10th Oct 20234:49 pmRNSProposed secondary placing in Trustpilot Group PLC
3rd Oct 20237:00 amRNSTrustpilot launches Reviews for Salesforce
27th Sep 202312:00 pmRNSDirector/PDMR Shareholding
25th Sep 202310:00 amRNSTR-1 - Notification of major holdings
21st Sep 202312:00 pmRNSDirector/PDMR Shareholding
21st Sep 202312:00 pmRNSPDMR notification - grant of LTIP award
19th Sep 20237:00 amRNSResults for the six months ended 30 June 2023
13th Sep 20234:01 pmRNSDirectorate Change
31st Aug 20232:18 pmRNSTotal Voting Rights
31st Jul 20233:00 pmRNSTotal Voting Rights
17th Jul 20237:00 amRNSAppointment of Chief Executive Officer
13th Jul 20237:00 amRNSTrading Statement
3rd Jul 20233:50 pmRNSTR-1 - Notification of major holdings
3rd Jul 20237:00 amRNSBlock listing Interim Review
30th Jun 20233:26 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20231:58 pmRNSTotal Voting Rights
23rd May 20235:14 pmRNSResult of AGM
28th Apr 20232:45 pmRNSTotal Voting Rights
19th Apr 20235:04 pmRNSAnnual Financial Report
11th Apr 202312:13 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:11 pmRNSDirector/PDMR Shareholding
31st Mar 20233:42 pmRNSTotal Voting Rights
30th Mar 20234:13 pmRNSDirector Declaration
28th Mar 20237:00 amRNSPDMR notification - grant of LTIP awards
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
21st Mar 20237:00 amRNSResults for the year ended 31 December 2022
21st Mar 20237:00 amRNSUpdate regarding management transition
13th Mar 20237:00 amRNSUpdate regarding liquidity position and resilience
28th Feb 20232:30 pmRNSTotal Voting Rights
24th Feb 20237:00 amRNSChair Succession
13th Feb 20239:20 amRNSTR-1 - Notification of major holdings
8th Feb 202311:52 amRNSTR-1 - Notification of major holdings
31st Jan 20232:25 pmRNSTotal Voting Rights
20th Jan 20237:00 amRNSTR-1 - Notification of major holdings
12th Jan 20237:00 amRNSTrading update for the year to 31 Dec 2022
10th Jan 20237:00 amRNSBlock Listing Application
3rd Jan 20237:00 amRNSBlock listing Interim Review
30th Dec 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.